Form 4: Teladoc Health Director David L. Shedlarz Reports Stock Transactions
SEC Form 4 Filing
Director David L. Shedlarz reports acquisition of 17,467 restricted stock units and conversion of 9,834 restricted stock units into common stock.
Summary
- On May 22, 2024, Director David L. Shedlarz converted 9,834 restricted stock units into shares of Teladoc Health common stock.
- These restricted stock units vested in full on May 22, 2024, after being granted on May 25, 2023.
- On May 23, 2024, Shedlarz acquired 17,467 restricted stock units, which vest in full on the earlier of May 23, 2025, or the day before the company's 2025 annual meeting of stockholders.
- Following these transactions, Shedlarz directly owns 14,813 shares of common stock and 17,467 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company director, which has a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common practice for publicly traded companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the director's holdings.
Key Dates
| Date | Description |
|---|---|
| 05/25/2023 | Reporting person was granted 9,834 restricted stock units. |
| 05/22/2024 | 9,834 restricted stock units vested in full and converted to common stock. |
| 05/23/2024 | Reporting person acquired 17,467 restricted stock units. |
| 05/23/2025 | 17,467 restricted stock units vest in full on the earlier of this date or the day immediately preceding the issuer's 2025 annual meeting of stockholders. |
| 05/24/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.